Tandem Diabetes Care | TNDM - Equity Capital And Reserves



Tandem Diabetes Care reported $133.28M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Abbott USD 50.83B 1.76B Jun/2025
Align Technology USD 3.79B 57.74M Mar/2025
AtriCure USD 464.49M 9.87M Jun/2025
Baxter International USD 7.05B 90M Mar/2025
Becton, Dickinson and Co. USD 25.47B 231M Jun/2025
Boston Scientific USD 22.21B 443M Mar/2025
Cooper Companies USD 8.35B 64.9M Jul/2025
Dexcom USD 2.57B 306.5M Jun/2025
Edwards Lifesciences USD 10.19B 193.2M Mar/2025
Eli Lilly USD 18.27B 2.43B Jun/2025
Globus Medical USD 4.3B 207.61M Jun/2025
ICU Medical USD 2.12B 128.09M Jun/2025
Insulet USD 1.46B 132.2M Jun/2025
Integra LifeSciences USD 1.04B 485.48M Jun/2025
Intuitive Surgical USD 17.95B 745.4M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Masimo USD 1.04B 96.4M Jun/2025
Medtronic USD 48.02B 1.36B Apr/2025
Merit Medical Systems USD 1.49B 59.62M Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Stryker USD 21.19B 261M Jun/2025
Tandem Diabetes Care USD 133.28M 22.01M Jun/2025
Teleflex USD 4.24B 147.7M Jun/2025
Zimmer Biomet Holdings USD 12.53B 130.5M Jun/2025